Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Cogent Biosciences, Inc.
IPO Date: March 26, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $1.82B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.27 | 3.20%
Avg Daily Range (30 D): $0.21 | 1.80%
Avg Daily Range (90 D): $0.22 | 2.78%
Institutional Daily Volume
Avg Daily Volume: .59M
Avg Daily Volume (30 D): 1.14M
Avg Daily Volume (90 D): 1.98M
Trade Size
Avg Trade Size (Sh.): 108
Avg Trade Size (Sh.) (30 D): 75
Avg Trade Size (Sh.) (90 D): 109
Institutional Trades
Total Inst.Trades: 1,701
Avg Inst. Trade: $1.61M
Avg Inst. Trade (30 D): $1.86M
Avg Inst. Trade (90 D): $1.68M
Avg Inst. Trade Volume: .18M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.8M
Avg Closing Trade (30 D): $2.45M
Avg Closing Trade (90 D): $2.41M
Avg Closing Volume: 190.84K
   
News
Jul 9, 2025 @ 1:36 AM
Cogent Biosciences Announces Pricing of Upsized Pu...
Source: Christi Waarich
Apr 15, 2025 @ 5:00 PM
Gastrointestinal Stromal Tumor Market to Grow Rapi...
Source: Delveinsight
Jun 28, 2024 @ 1:18 PM
Cogent (COGT) Up on SUMMIT Study Update Post Posit...
Source: Zacks Equity Research
Jun 14, 2024 @ 11:30 AM
Cogent Biosciences Announces Additional Clinical D...
Source: Cogent Biosciences, Inc.
May 23, 2024 @ 9:05 PM
Cogent Biosciences Appoints Cole Pinnow as Chief C...
Source: Cogent Biosciences, Inc.
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $-1.78 $-.53 $-.52
Diluted EPS $-1.78 $-.53 $-.52
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -284.08M $ -73.53M $ -71.99M
Operating Income / Loss $ -299.66M $ -75.58M $ -74.93M
Cost of Revenue $ $ $
Net Cash Flow $ 39.38M $ 1.6M $ 27.84M
PE Ratio    
Splits
Nov 09, 2020:   1:4